-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.
-
Summary
-
Mirati Therapeutics, Inc. quarterly/annual Net Cash Provided by (Used in) Investing Activities history and growth rate from 2012 to 2022.
- Mirati Therapeutics, Inc. Net Cash Provided by (Used in) Investing Activities for the quarter ending March 31, 2023 was $195M, a 294% increase year-over-year.
- Mirati Therapeutics, Inc. annual Net Cash Provided by (Used in) Investing Activities for 2022 was $226M.
- Mirati Therapeutics, Inc. annual Net Cash Provided by (Used in) Investing Activities for 2021 was -$589M, a 321% decline from 2020.
- Mirati Therapeutics, Inc. annual Net Cash Provided by (Used in) Investing Activities for 2020 was -$140M, a 20.6% increase from 2019.
Net Cash Provided by (Used in) Investing Activities, Annual (USD)
Net Cash Provided by (Used in) Investing Activities, YoY Annual Growth (%)